Invasive monitoring for intractable epilepsy is useful when the epileptogenic focus is in question even after an extensive noninvasive presurgical evaluation, or when the epileptogenic focus is located in or near eloquent cortex. From June 1989 to June 2001 at the Children’s Hospital of Philadelphia, 64 children with intractable epilepsy underwent 67 invasive monitoring procedures as part of their presurgical evaluation. The average age at implantation was 10 years. In all but two cases, subdural strips and grids were used. Depth electrodes, when used, were placed stereotactically or under direct vision. The average duration of the monitoring period was 5.87 days. Every patient had intradural cultures sent during removal of the electrodes, and lumbar punctures were performed in 15 patients. Twenty-one patients had at least one episode of a CSF leak. Of the 67 patients, 10 had positive intradural cultures, only 1 of whom had a positive lumbar puncture and none of whom developed clinically significant meningitis. No clinically relevant hemorrhages occurred as a result of the invasive monitoring. One patient did have a transient visual field loss after placement of an occipital grid. While CSF leaks are common after invasive monitoring despite precautions, clinically significant CSF infections are uncommon and appear to be unrelated to the duration of monitoring, the occurrence of a CSF leak or the length of time the patient is on perioperative antibiotics. We conclude that invasive monitoring for intractable epilepsy is generally safe.

Keywords:
Epilepsy, Invasive monitoring, Pediatric epilepsy, Complications, Infection
1.
Duchowny M, Jayakar P, Koh S: Selection criteria and preoperative investigation of patients with focal epilepsy who lack a localized structural lesion. Epileptic Disord 2000;2:219–226.
2.
Bruce DA, Bizzi JW: Surgical technique for the insertion of grids and strips for invasive monitoring in children with intractable epilepsy. Childs Nerv Syst 2000;16:724–730.
3.
Cukiert A, Buratini JA, Machado E, Sousa A, Vieira JO, Argentoni M, Forster C, Baldauf C: Results of surgery in patients with refractory extratemporal epilepsy with normal or nonlocalizing magnetic resonance findings investigated with subdural grids. Epilepsia 2001;42:889–894.
4.
Jayakar P: Invasive EEG monitoring in children: When, where, and what? J Clin Neurophysiol 1999;16:408–418.
5.
Jayakar P, Duchowny M, Resnick TJ: Subdural monitoring in the evaluation of children for epilepsy surgery. J Child Neurol 1994;9(suppl 2):61–66.
6.
Adelson PD, Black PM, Madsen JR, Kramer U, Rockoff MA, Riviello JJ, Helmers SL, Mikati M, Holmes GL: Use of subdural grids and strip electrodes to identify a seizure focus in children. Pediatr Neurosurg 1995;22:174–180.
7.
Snead OC 3rd: Surgical treatment of medically refractory epilepsy in childhood. Brain Dev 2001;23:199–207.
8.
Adelson PD, O’Rourke DK, Albright AL: Chronic invasive monitoring for identifying seizure foci in children. Neurosurg Clin N Am 1995;6:491–504.
9.
Behrens E, Zentner J, van Roost D, Hufnagel A, Elger CE, Schramm J: Subdural and depth electrodes in the presurgical evaluation of epilepsy. Acta Neurochir (Wien) 1994;128:84–87.
10.
Blatt DR, Roper SN, Friedman WA: Invasive monitoring of limbic epilepsy using stereotactic depth and subdural strip electrodes: Surgical technique. Surg Neurol 1997;48:74–79.
11.
Wiggins GC, Elisevich K, Smith BJ: Morbidity and infection in combined subdural grid and strip electrode investigation for intractable epilepsy. Epilepsy Res 1999;37:73–80.
12.
Lee WS, Lee JK, Lee SA, Kang JK, Ko TS: Complications and results of subdural grid electrode implantation in epilepsy surgery. Surg Neurol 2000;54:346–351.
13.
Siegel AM, Jobst BC, Thadani VM, Rhodes CH, Lewis PJ, Roberts DW, Williamson PD: Medically intractable, localization-related epilepsy with normal MRI: Presurgical evaluation and surgical outcome in 43 patients. Epilepsia 2001;42:883–888.
14.
Swartz BE, Rich JR, Dwan PS, DeSalles AA, Kaufman MH, Walsh GO, Delgado-Escueta AV: The safety and efficacy of chronically implanted subdural electrodes: A prospective study. Surg Neurol 1996;46:87–93.
15.
Wyler AR, Walker G, Somes G: The morbidity of long-term seizure monitoring using subdural strip electrodes. J Neurosurg 1991;74:734–737.
16.
Wyllie E, Luders H, Morris HH 3rd, Lesser RP, Dinner DS, Rothner AD, Erenberg G, Cruse R, Friedman D, Hahn J, et al: Subdural electrodes in the evaluation for epilepsy surgery in children and adults. Neuropediatrics 1988;19:80–86.
17.
Zumsteg D, Wieser HG: Presurgical evaluation: Current role of invasive EEG. Epilepsia 2000;41(suppl 3):S55–S60.
18.
Siegel AM, Roberts DW, Thadani VM, McInerney J, Jobst BC, Williamson PD: The role of intracranial electrode reevaluation in epilepsy patients after failed initial invasive monitoring. Epilepsia 2000;41:571–580.
19.
Ross D, Brunberg J, Drury I, Henry T: Intracerebral depth electrode monitoring in partial epilepsy: The morbidity and efficacy of placement using magnetic resonance image-guided stereotactic surgery. Neurosurgery 1996;39:327–334.
20.
Weinand ME, Oommen KJ: Lumbar cerebral spinal fluid drainage during long-term electrocorticographic monitoring with subdural strip electrodes: Elimination of cerebral spinal fluid leak. Seizure 1993;2:133–136.
© 2003 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.